Prof Alison Birtle (Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK), Dr Ignacio Durán (Marques de Valdecilla University Hospital, Santander, Spain) and Dr Patrizia Giannatempo (RCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy) discuss highlights in bladder cancer treatment research from the first half of 2024.

The panel cover the ASCO GU, EAU, ASCO and AUA meetings and discuss the potential impact of key research, including:

• Novel or unexpected data
• NMIBC
• Nodal management
• Perioperative therapy in UC
• Advanced disease, variant histologies and FGFR